NIFE — Direxion Fallen Knives ETF
Data updated: 2022-09-29
NIFE — Direxion Fallen Knives ETF. United States Small Cap Value Equity · $2.38M AUM · 0.50% expense ratio. Holdings, fees, performance and SEC filings.
NIFE Fund Overview
NIFE — Direxion Fallen Knives ETF is a US ETF managed by Direxion Shares ETF Trust, categorised as United States Small Cap Value Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US ETF
- Manager: Direxion Shares ETF Trust
- Category: United States Small Cap Value Equity
- Assets under management: $2.38M
- 1-year return: -31.6%
- Ticker: NIFE
- SEC CIK: 0001424958
- SEC series ID: S000068623
- Share class ID: C000219529
NIFE Investment Objective and Strategy
Direxion Fallen Knives ETF describes its objective and strategy as follows, from its latest prospectus filed with the SEC by Direxion Shares ETF Trust.
Investment objective
The Direxion Fallen Knives ETF (the Fund) seeks investment results, before fees and expenses, that track the Indxx US Fallen Knives Index (the Index).
Principal investment strategy
The Fund, under normal circumstances, invests at least 80% of its net assets (plus any borrowings for investment purposes) in the securities that comprise the Index or investments with economic characteristics similar to the securities included in the Index. The Index is designed by Indxx, LLC (the Index Provider) to consist of U.S equity securities that have experienced considerable share price declines (greater than 15%) over the prior year but have financial health, suggesting that the security has potential for share price recovery in the future. Securities that are listed in the United States, with a minimum total market capitalization of $500 million, and that have traded regularly in the prior 6 months are eligible for inclusion in the Index. The Index Provider calculates a composite financial health score for each security based on its current ratio (current assets divided by current liabilities), cash flow coverage ratio, and debt-to-equity ratio.
The top 50 securities with the highest composite financial health score are included in the Index. Securities included in the Index are weighted based on free-float adjusted market capitalization subject to a cap of 4.9% of the value of the Index. The Index is reconstituted annually and rebalanced quarterly. As of December 31, 2021, the Index was comprised of 49 constituents, which had a median total market capitalization of $1.8 billion, total market capitalizations ranging from $120.5 million to $28.8 billion and were concentrated in the healthcare and information technology sectors. The components of the Index and the percentages represented by various sectors in the Index may change over time. The Fund will concentrate its investment in a particular industry or group of industries ( i.e.
, hold 25% or more of its total assets in the stocks of a particular industry or group of industries) to approximately the same extent as the Index is so concentrated. The Fund uses a passive or indexing approach to attempt to achieve its investment objective. Although the Fund intends to fully replicate the Index, at times the Fund may hold a representative sample of the securities in the Index that have aggregate characteristics similar to those of the Index. This means the Fund may not hold all of the securities included in the Index, its weighting of investment exposure to such securities or industries may be different from that of the Index and it may hold securities that are not included in the Index. The Fund will rebalance its portfolio when the Index rebalances. Additionally, if the Fund receives a creation unit in cash, the Fund repositions its portfolio in response to assets flowing into or out of the Fund.
The Fund is non-diversified, meaning that a relatively high percentage of its assets may be invested in a limited number of issuers of securities. Additionally, the Funds investment objective is not a fundamental policy and may be changed by the Funds Board of Trustees without shareholder approval.
NIFE Performance
Total returns for NIFE (as of 2026-10-01), from SEC filings.
| Period | Total return |
|---|---|
| 1 year | -31.6% |
| 3 years (annualised) | 3.1% |
NIFE Risk Information
Risk metrics for NIFE, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 20.1%
NIFE Costs and Fees
NIFE costs about $50 per $10,000 invested per year in fund expenses.
- Net expense ratio: 0.50%
- Gross expense ratio: 0.50%
- Portfolio turnover: 113%
- Brokerage commissions: 4.38 bps of average net assets (SEC N-CEN)
NIFE Cashflows
Over the 12 months to 2022-07, Direxion Fallen Knives ETF had net inflows of $4.67M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2022-07 | $1.19M |
| 2022-06 | $0 |
| 2022-05 | $0 |
| 2022-04 | $0 |
| 2022-03 | $0 |
| 2022-02 | $0 |
NIFE Debt Constituents
No individual debt constituents are reported in Direxion Fallen Knives ETF's latest SEC N-PORT filing.
NIFE Prospectus and SEC Filings
Official Direxion Fallen Knives ETF filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
- Prospectus (485BPOS) — filed 2022-02-28
- Prospectus (485BPOS) — filed 2021-02-26
- Prospectus (485BPOS) — filed 2020-06-10
- Portfolio holdings (N-PORT) — filed 2022-09-29
- Portfolio holdings (N-PORT) — filed 2022-06-29
- Portfolio holdings (N-PORT) — filed 2022-04-01
- Annual census (N-CEN) — filed 2022-01-12
- Annual census (N-CEN) — filed 2021-01-13
Related Funds
Other United States Small Cap Value Equity funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.